WallStSmart
ACET

Adicet Bio Inc

NASDAQ: ACET · HEALTHCARE · BIOTECHNOLOGY

$8.17
-10.92% today

Updated 2026-06-05

Market cap
$82.08M
P/E ratio
P/S ratio
9.72x
EPS (TTM)
$-13.87
Dividend yield
52W range
$6 – $17
Volume
0.1M

Adicet Bio Inc (ACET) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-77.70%
ROA
-39.40%
Debt/equity
0.10x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2008$359.59M$13.47M18.72%5.94%3.75%
2009$322.65M$8.63M17.24%3.69%2.67%
2010$346.63M$6.58M15.62%2.72%1.90%
2011$412.43M$8.97M15.96%4.01%2.17%
2012$444.39M$16.98M18.46%5.71%3.82%
2013$499.69M$22.33M19.67%6.89%4.47%
2014$499.69M$22.33M19.67%6.89%4.47%
2015$510.18M$29.00M22.48%8.68%5.68%
2016$546.95M$-1000.0024.76%-0.00%-0.00%
2017$558.52M$-33.78M100.00%-3.38%-6.05%
2018$8.18M$-9.30M99.02%-182.91%-113.67%
2019$995000.00$-28.14M100.00%-3,154.57%-2,827.94%
2020$17.90M$-36.68M100.00%-218.91%-204.87%
2021$9.73M$-62.00M100.00%-631.38%-637.19%
2022$24.99M$-69.79M100.00%-290.32%-279.27%
2023$0.00$-142.66M
2024$0.00$-117.12M
2025$0.00$-116.80M

Frequently asked questions

How much free cash flow does ACET generate?

ACET produced $-96.98M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ACET's balance sheet healthy?

ACET holds $38.92M in cash and equivalents against — in long-term debt, on $159.21M of shareholder equity. That debt is best read against the cash flow the business throws off each year.